You are here

Article info

Article menu
Download PDFPDF
Multiple sclerosis
Short report
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis

Authors

  1. Correspondence to Dr Antoine Guéguen, Department of Neurology, Fondation Ophtalmologique A. de Rothschild, 25–29, rue Manin, Paris 75019, France; agueguen{at}fo-rothschild.fr
View Full Text

Citation

Gueguen A, Roux P, Deschamps R, et al
Abnormal inflammatory activity returns after natalizumab cessation in multiple sclerosis
Journal of Neurology, Neurosurgery & Psychiatry 2014;85:1038-1040.

Publication history

  • Received January 8, 2014
  • Revised April 30, 2014
  • Accepted May 8, 2014
  • First published May 29, 2014.
Online issue publication 
April 13, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions